Abstract
In the last few decades cancer immunotherapy has evolved as an alternative strategy for cancer treatment. A variety of approaches including monoclonal antibodies, cancer vaccines, chimeric antigen receptor T-cell therapy, immune checkpoint therapy, oncolytic virus therapy, and nonspecific immunotherapy have revolutionized traditional cancer treatment. In addition to these therapies, various immune booster drugs such as thalidomide, lenalidomide, and pomalidomide have also been reported to produce anticancer action. Since the 1980s, many novel immunotherapy treatments have been tested and approved for cancer treatment. This chapter covers all the reported immunotherapies for cancer treatment in detail.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nanotechnology Applications for Cancer Chemotherapy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
